| 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of … F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ... European heart journal 41 (1), 111-188, 2020 | 8289 | 2020 |
| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016 | 4684 | 2016 |
| 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) V Aboyans, JB Ricco, ML Bartelink, M Björck, M Brodmann, T Cohner, ... Kardiologia Polska (Polish Heart Journal) 75 (11), 1065-1160, 2017 | 4620* | 2017 |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with … FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... European journal of preventive cardiology 29 (1), 5-115, 2022 | 4256 | 2022 |
| ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European … Ž Reiner, AL Catapano, G De Backer, I Graham, MR Taskinen, O Wiklund, ... European heart journal 32 (14), 1769-1818, 2011 | 3844 | 2011 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European … BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ... European heart journal 38 (32), 2459-2472, 2017 | 3287 | 2017 |
| Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ... European heart journal 36 (17), 1012-1022, 2015 | 1512 | 2015 |
| EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries K Kotseva, D Wood, D De Bacquer, G De Backer, L Rydén, C Jennings, ... European journal of preventive cardiology 23 (6), 636-648, 2016 | 1300 | 2016 |
| Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European … J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ... European heart journal 41 (24), 2313-2330, 2020 | 1077 | 2020 |
| European Society of Cardiology: cardiovascular disease statistics 2017 A Timmis, N Townsend, C Gale, R Grobbee, N Maniadakis, M Flather, ... European heart journal 39 (7), 508-579, 2018 | 946 | 2018 |
| International physical activity questionnaire: reliability and validity of the Turkish version M Saglam, H Arikan, S Savci, D Inal-Ince, M Bosnak-Guclu, E Karabulut, ... Perceptual and motor skills 111 (1), 278-284, 2010 | 879 | 2010 |
| Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry K Kotseva, G De Backer, D De Bacquer, L Rydén, A Hoes, D Grobbee, ... European journal of preventive cardiology 26 (8), 824-835, 2019 | 802 | 2019 |
| Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular … MP Bonaca, P Nault, RP Giugliano, AC Keech, AL Pineda, E Kanevsky, ... Circulation 137 (4), 338-350, 2018 | 704 | 2018 |
| ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of … European Association for Cardiovascular Prevention & Rehabilitation, ... Eur Heart J 32 (14), 1769-818, 2011 | 477 | 2011 |
| Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ... European heart journal 43 (39), 3925-3946, 2022 | 437 | 2022 |
| Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series BA Ference, I Graham, L Tokgozoglu, AL Catapano Journal of the American College of Cardiology 72 (10), 1141-1156, 2018 | 420 | 2018 |
| ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice FLJ Visseren, F Mach, YM Smulders, D Carballo, KC Koskinas, M Bäck, ... Eur Heart J 42 (34), 3227-3337, 2021 | 412 | 2021 |
| Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus … HN Ginsberg, CJ Packard, MJ Chapman, J Borén, CA Aguilar-Salinas, ... European heart journal 42 (47), 4791-4806, 2021 | 399 | 2021 |
| Adverse effects of statin therapy: perception vs. the evidence–focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract F Mach, KK Ray, O Wiklund, A Corsini, AL Catapano, E Bruckert, ... European heart journal 39 (27), 2526-2539, 2018 | 388 | 2018 |
| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 306 | 2019 |
